Bnp Paribas Arbitrage, Snc »

Bridgebio Pharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 1.7M 1.69

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
State Street SPDR S&P Biotech ETF Fund (XBI)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Alphabet Equity (GOOG)
JPMorgan Chase & Co Equity (JPM)
Meta Platforms Equity (META)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Micron Technology Equity (MU)
iShares Russell 2000 ETF Fund (IWM)
Oracle Corp Equity (ORCL)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Bridgebio Pharma

D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
CSS
Alberta Investment Management Corporation
Calamos Advisors
Ameriprise Financial
Wolverine Asset Management
SSI Investment Management
Bank of America Corporation
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc

View all funds holding Bridgebio Pharma